Tiboni v. Merck Frosst Canada Ltd.Posted March 5, 2016
The drug Vioxx was withdrawn from the market worldwide on September 30, 2004 following reports that its users faced a significantly higher risk of cardiovascular complications, including heart attack, stroke, angina, blood clots and congestive heart failure. Multiple class actions were commenced across Canada. Ultimately, one class action was certified out of Ontario for a national class, excluding individuals resident in Quebec or Saskatchewan. That class action was managed by a group of multiple law firms across Canada. A Canada-Wide Settlement Agreement was reached in 2012 and approved in 2013. Please note that Lerners LLP is no longer involved in this class action. Details regarding this class action may be obtained at the Vioxx National Class Action Canada website.